Larimar Therapeutics's total assets for Q1 2026 were $208.51M, an increase of 42.97% from the previous quarter. LRMR total liabilities were $50.48M for the fiscal quarter, a -25.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.